Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "stroke"

101 News Found

A 10-year commission with dedicated mission is required to tackle the upsurge of diabetes in India: says Expert
Healthcare | September 01, 2022

A 10-year commission with dedicated mission is required to tackle the upsurge of diabetes in India: says Expert

India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved


Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes
News | August 02, 2022

Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes

The two generic drugs have been launched under the brand names Jankey & Sitenali.


Think twice even before you start thinking on smoking!
Opinion | July 18, 2022

Think twice even before you start thinking on smoking!

Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs


SRL Diagnostics launches fatty liver index
Diagnostic Center | July 13, 2022

SRL Diagnostics launches fatty liver index

An algorithm based testing for Fatty Liver Disease


Feeling younger can help us rehabilitate faster : Study
News | July 11, 2022

Feeling younger can help us rehabilitate faster : Study

Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity


Rivaroxaban approved in Japan for patients with PAD after revascularisation
Drug Approval | June 24, 2022

Rivaroxaban approved in Japan for patients with PAD after revascularisation

It´s the first trial to demonstrate the benefits of dual pathway inhibition


Apollo Hospitals completes a procedure using new technology SENTINEL
Healthcare | June 16, 2022

Apollo Hospitals completes a procedure using new technology SENTINEL

Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.


Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India
Drug Approval | May 18, 2022

Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India

Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia


Zydus launches Bemdac to treat LDL-Cholesterol
Drug Approval | May 14, 2022

Zydus launches Bemdac to treat LDL-Cholesterol

It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins


Gut microbiome as a tool in regenerative medicine
Biotech | May 07, 2022

Gut microbiome as a tool in regenerative medicine

Novel approach driven by GN Corp Japan with potentials in neurological illnesses